Titlebook: Cystic Fibrosis in Primary Care; An Essential Guide t Douglas Lewis, MD, FAAFP Book 2020 Springer Nature Switzerland AG 2020 cystic fibrosi

遺留之物

Acute and Chronic Infection Management in CF,egies for managing infectious complications of CF patients include chronic prophylactic antibiotics, use of systemic as well as inhaled antibiotics, mechanical assistance with mucus clearance, and scrupulous infection control measures.

acrimony

CFTR Corrector Therapies/New Therapies,ies have been developed and are currently available for about 50% of the CF population within the United States. Further therapeutics, including genetic therapy options, are in various stages of development with the eventual hope of providing CFTR modulating and/or genetic therapy options for all individuals with CF.

bisphosphonate

Evolution of Cystic Fibrosis Care,ts is now multidisciplinary, yet must reflect the whole person rather than individual organ systems. The general pediatrician and the family physician have a role to play in the care of these patients because of the unique whole-person perspective practiced in these primary care disciplines.

flamboyant

CF Basics,ew cases are now identified by newborn screening. New treatments have greatly increased the life expectancy of patients with the disease, and now more than half of the CF patients in the United States are adults. CFTR modulating medications are changing the trajectory of the disease, as they are highly effective at restoring CFTR function.

indifferent

不能平靜

Sleep-Paralysis

CFTR Carrier Status,ase states depending on the mutations at the cystic fibrosis transmembrane conductance regulator (CFTR) gene, modifier genes, environmental influences, and other factors. The CF carrier state is not necessarily asymptomatic or disease-free. Rather, CFTR-related disease (CFTR-RD) can affect the same organ systems involved in the CF patient.

deforestation

Osteons

Spondyloarthropathies and Gut Microbiotaase states depending on the mutations at the cystic fibrosis transmembrane conductance regulator (CFTR) gene, modifier genes, environmental influences, and other factors. The CF carrier state is not necessarily asymptomatic or disease-free. Rather, CFTR-related disease (CFTR-RD) can affect the same organ systems involved in the CF patient.

花束